Hui Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Hui Wang has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
- Baowei Jiao
National Key Laboratory of Genetic Evolution & Animal Models, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, China
4 shared publications Li Zou
National Key Laboratory of Genetic Evolution & Animal Models, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, China
4 shared publicationsQin Yang
National Key Laboratory of Genetic Evolution & Animal Models, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, China
4 shared publications- Xu Yang
National Key Laboratory of Genetic Evolution & Animal Models, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, China
2 shared publications B. Jiao
National Key Laboratory of Genetic Evolution & Animal Models, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan, China
1 shared publication- Baowei Han
Luoyang Maternal and Child Health Hospital, China
1 shared publication
Latest Publications
- 22 September 2026
- Published by Pleiades Publishing Ltd in Molecular Biology
- p. 1-12
Rab13 Activates IL-6/STAT3 Pathway for Maintaining Stemness of Breast Tumors
Breast cancer remains a significant global health concern, characterized by its heterogeneity. Cancer stem cells (CSCs) contribute to tumor heterogeneity, drug resistance, and ultimately, cancer recurrence. The IL‑6/Signal Transducer and Activator of Transcription 3 (STAT3) signaling pathway is critical for maintaining the breast cancer stem cells (BCSCs) stemness; however, the upstream regulatory mechanisms remain unclear. Here, we report that Rab13, a member of the Rab GTPase family, regulates IL‑6/STAT3 signaling to sustain the BCSCs phenotype. In HCC1806 and MDA‑MB‑231 breast cancer cells, Rab13 knockdown reduced membrane localization of IL-6 receptor (IL-6Rα), impaired IL‑6‑induced STAT3 phosphorylation, and reduced the proportions of CD44+CD24−/low and ALDH+ BCSCs populations. Rab13 depletion also inhibited tumorsphere formation, soft agar colony formation, cell migration, cell invasion, and epithelial‑mesenchymal transition (EMT). Mechanistically, Rab13 interacts with IL‑6Rα and mediates its membrane trafficking, thereby ensuring efficient IL‑6/STAT3 signaling. Activation of STAT3 by ML115 rescued the BCSCs stemness and EMT defects caused by Rab13 knockdown. These findings reveal that Rab13 maintains BCSCs stemness and promotes tumor progression via the IL‑6/STAT3‑EMT axis, suggesting Rab13 as a potential therapeutic target for breast cancer.
- 22 September 2026
- Published by Pleiades Publishing Ltd in Molecular Biology
- p. 1-12
Rab13 Activates IL-6/STAT3 Pathway for Maintaining Stemness of Breast Tumors
Breast cancer remains a significant global health concern, characterized by its heterogeneity. Cancer stem cells (CSCs) contribute to tumor heterogeneity, drug resistance, and ultimately, cancer recurrence. The IL‑6/Signal Transducer and Activator of Transcription 3 (STAT3) signaling pathway is critical for maintaining the breast cancer stem cells (BCSCs) stemness; however, the upstream regulatory mechanisms remain unclear. Here, we report that Rab13, a member of the Rab GTPase family, regulates IL‑6/STAT3 signaling to sustain the BCSCs phenotype. In HCC1806 and MDA‑MB‑231 breast cancer cells, Rab13 knockdown reduced membrane localization of IL-6 receptor (IL-6Rα), impaired IL‑6‑induced STAT3 phosphorylation, and reduced the proportions of CD44+CD24−/low and ALDH+ BCSCs populations. Rab13 depletion also inhibited tumorsphere formation, soft agar colony formation, cell migration, cell invasion, and epithelial‑mesenchymal transition (EMT). Mechanistically, Rab13 interacts with IL‑6Rα and mediates its membrane trafficking, thereby ensuring efficient IL‑6/STAT3 signaling. Activation of STAT3 by ML115 rescued the BCSCs stemness and EMT defects caused by Rab13 knockdown. These findings reveal that Rab13 maintains BCSCs stemness and promotes tumor progression via the IL‑6/STAT3‑EMT axis, suggesting Rab13 as a potential therapeutic target for breast cancer.
- Open Access
- 30 January 2026
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (2) , 181
Atlas-Guided Nanocarrier Strategies Targeting Spatial NTRK2/MAPK Signaling in EGFR-TKI-Resistant Niches of Esophageal Squamous Cell Carcinoma
Esophageal squamous cell carcinoma (ESCC) represents a major therapeutic challenge due to the rapid development of resistance to epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs). Recent evidence highlights that this resistance is driven not only by genetic mutations but also by spatial heterogeneity of tumor microenvironments and compensatory signaling mechanisms. In this review, we propose a “spatial-signaling-intervention” framework with a particular focus on the NTRK2/MAPK signaling axis, which plays dual roles in signaling compensation and immune evasion. By integrating spatial multi-omics, proteomics, and AI-assisted topological modeling, three resistant niches are identified: (1) cancer stemness-enriched zones, (2) MAPK hyperactive islands, and (3) immune-cold regions. Based on this atlas, we design precision nanotherapeutic platforms, including responsive, dual-target, and feedback-loop nanocarriers, to selectively modulate resistant spatial niches. Preclinical validation in patient-derived xenografts and organoid models further demonstrates the translational potential of these strategies. This work provides a conceptual and technological roadmap for overcoming EGFR-TKI resistance in ESCC. Atlas-guided nanocarrier systems offer a promising avenue for spatially targeted and feedback-responsive therapy, highlighting the role of pharmaceutics in advancing precision oncology.
- 30 January 2026
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (2) , 181
Open AccessAtlas-Guided Nanocarrier Strategies Targeting Spatial NTRK2/MAPK Signaling in EGFR-TKI-Resistant Niches of Esophageal Squamous Cell Carcinoma
Esophageal squamous cell carcinoma (ESCC) represents a major therapeutic challenge due to the rapid development of resistance to epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs). Recent evidence highlights that this resistance is driven not only by genetic mutations but also by spatial heterogeneity of tumor microenvironments and compensatory signaling mechanisms. In this review, we propose a “spatial-signaling-intervention” framework with a particular focus on the NTRK2/MAPK signaling axis, which plays dual roles in signaling compensation and immune evasion. By integrating spatial multi-omics, proteomics, and AI-assisted topological modeling, three resistant niches are identified: (1) cancer stemness-enriched zones, (2) MAPK hyperactive islands, and (3) immune-cold regions. Based on this atlas, we design precision nanotherapeutic platforms, including responsive, dual-target, and feedback-loop nanocarriers, to selectively modulate resistant spatial niches. Preclinical validation in patient-derived xenografts and organoid models further demonstrates the translational potential of these strategies. This work provides a conceptual and technological roadmap for overcoming EGFR-TKI resistance in ESCC. Atlas-guided nanocarrier systems offer a promising avenue for spatially targeted and feedback-responsive therapy, highlighting the role of pharmaceutics in advancing precision oncology.
- Open Access
- 15 October 2025
- Published by Springer Nature in BMC Genomics
- Vol. 26 (1) , 1-14
The key role of acss1 in mammary gland development and lactation: a study based on gene co-expression network analysis
Lactation physiological activity plays a key role in maternal health as well as infant nutrition and growth. The complex gene regulatory networks of lactation remain largely unexplored during mammary gland development. A deeper understanding of these processes is essential for identifying potential therapeutic targets to improve lactation efficiency. We employed Gene Co-expression Network Analysis (WGCNA) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis to identify the gene expression patterns, regulatory mechanisms and cellular signaling pathways involved in mammary gland development during pregnancy and lactation. Quantitative real-time polymerase chain reaction (qRT-PCR) was used to validate gene expression in mRNA levels at different stages of mammary development. Immunohistochemical staining was carried out to detect the protein level of ACSS1 at different stages of mammary development. Lactogenic differentiation assay and triglyceride (TAG) secretion detection were applied to investigate the effect of Acss1 on lactogenic differentiation and milk lipid metabolism during lactation. We identified 23 gene modules, among which 8 modules were activated during pregnancy and lactation stage of mammary gland development. Cellular signaling pathways associated with mammary gland differentiation were enriched, including the FOXO and Wnt signaling pathways during pregnancy, as well as steroid biosynthesis and fatty acid metabolism during lactation. Among the identified genes, Acss1 emerged as a potential hub gene within module 8, exhibiting high connectivity with 312 other genes, and playing a critical role in lactogenic differentiation and milk lipid metabolism. Experimental validation showed that the gene expression pattern of Acss1 were highly consistent with microarray data at different stages of mammary gland development. Lactogenic differentiation assay and TAG secretion detection showed that Acss1 is crucial for lactogenic differentiation and affects the production and secretion of TAG during lactation in vitro. These findings suggesting Acss1 as a potential key regulatory factor of lactation efficiency.
- 15 October 2025
- Published by Springer Nature in BMC Genomics
- Vol. 26 (1) , 1-14
Open AccessThe key role of acss1 in mammary gland development and lactation: a study based on gene co-expression network analysis
Lactation physiological activity plays a key role in maternal health as well as infant nutrition and growth. The complex gene regulatory networks of lactation remain largely unexplored during mammary gland development. A deeper understanding of these processes is essential for identifying potential therapeutic targets to improve lactation efficiency. We employed Gene Co-expression Network Analysis (WGCNA) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis to identify the gene expression patterns, regulatory mechanisms and cellular signaling pathways involved in mammary gland development during pregnancy and lactation. Quantitative real-time polymerase chain reaction (qRT-PCR) was used to validate gene expression in mRNA levels at different stages of mammary development. Immunohistochemical staining was carried out to detect the protein level of ACSS1 at different stages of mammary development. Lactogenic differentiation assay and triglyceride (TAG) secretion detection were applied to investigate the effect of Acss1 on lactogenic differentiation and milk lipid metabolism during lactation. We identified 23 gene modules, among which 8 modules were activated during pregnancy and lactation stage of mammary gland development. Cellular signaling pathways associated with mammary gland differentiation were enriched, including the FOXO and Wnt signaling pathways during pregnancy, as well as steroid biosynthesis and fatty acid metabolism during lactation. Among the identified genes, Acss1 emerged as a potential hub gene within module 8, exhibiting high connectivity with 312 other genes, and playing a critical role in lactogenic differentiation and milk lipid metabolism. Experimental validation showed that the gene expression pattern of Acss1 were highly consistent with microarray data at different stages of mammary gland development. Lactogenic differentiation assay and TAG secretion detection showed that Acss1 is crucial for lactogenic differentiation and affects the production and secretion of TAG during lactation in vitro. These findings suggesting Acss1 as a potential key regulatory factor of lactation efficiency.
- 3 December 2024
- Published by Springer Nature in Oncogene
- Vol. 44 (8) , 545-556
Discovery of a molecular glue for EGFR degradation
Aberrant expression of epidermal growth factor receptor (EGFR) plays a critical role in the pathogenesis of various tumors, potentially representing a target for therapeutic intervention. Nonetheless, EGFR remains a challenging protein to target pharmacologically in triple-negative breast cancer (TNBC). An emerging approach to address the removal of such proteins is the application of molecular glue (MG) degraders. These compounds facilitate protein-protein interactions between a target protein and an E3-ubiquitin ligase, subsequently leading to protein degradation. Herein, we identified a new MG (CDDO-Me, C-28 methyl ester of 2-cyano-3, 12-dioxooleana-1, 9(11)-dien-28-oic acid), which orchestrated binding between EGFR and KEAP1 (an E3-ubiquitin ligase adapter), thereby initiating the ubiquitination and degradation of EGFR. CDDO-Me directly interacted with the tyrosine kinase (TK) domain of EGFR, resulting in its degradation via an autophagy-dependent lysosomal pathway. Knockdown of KEAP1 decreased the degradation of EGFR by reducing its K63-linked ubiquitination, leading to diminished EGFR colocalization in autophagosomes and lysosomes. Notably, CDDO-Me attenuates TNBC progression by accelerating EGFR degradation in cell-derived xenografts and patient-derived organoid models, highlighting its clinical application potential. Consequently, induction of EGFR degradation through MG degraders represents a viable therapeutic strategy for TNBC.
- 3 December 2024
- Published by Springer Nature in Oncogene
- Vol. 44 (8) , 545-556
Discovery of a molecular glue for EGFR degradation
Aberrant expression of epidermal growth factor receptor (EGFR) plays a critical role in the pathogenesis of various tumors, potentially representing a target for therapeutic intervention. Nonetheless, EGFR remains a challenging protein to target pharmacologically in triple-negative breast cancer (TNBC). An emerging approach to address the removal of such proteins is the application of molecular glue (MG) degraders. These compounds facilitate protein-protein interactions between a target protein and an E3-ubiquitin ligase, subsequently leading to protein degradation. Herein, we identified a new MG (CDDO-Me, C-28 methyl ester of 2-cyano-3, 12-dioxooleana-1, 9(11)-dien-28-oic acid), which orchestrated binding between EGFR and KEAP1 (an E3-ubiquitin ligase adapter), thereby initiating the ubiquitination and degradation of EGFR. CDDO-Me directly interacted with the tyrosine kinase (TK) domain of EGFR, resulting in its degradation via an autophagy-dependent lysosomal pathway. Knockdown of KEAP1 decreased the degradation of EGFR by reducing its K63-linked ubiquitination, leading to diminished EGFR colocalization in autophagosomes and lysosomes. Notably, CDDO-Me attenuates TNBC progression by accelerating EGFR degradation in cell-derived xenografts and patient-derived organoid models, highlighting its clinical application potential. Consequently, induction of EGFR degradation through MG degraders represents a viable therapeutic strategy for TNBC.
- Open Access
- 10 May 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-17
Fused in sarcoma (FUS) inhibits milk production efficiency in mammals
Efficient milk production in mammals confers evolutionary advantages by facilitating the transmission of energy from mother to offspring. However, the regulatory mechanism responsible for the gradual establishment of milk production efficiency in mammals, from marsupials to eutherians, remains elusive. Here, we find that mammary gland of the marsupial sugar glider contained milk components during adolescence, and that mammary gland development is less dynamically cyclic compared to that in placental mammals. Furthermore, fused in sarcoma (FUS) is found to be partially responsible for this establishment of low efficiency. In mouse model, FUS inhibit mammary epithelial cell differentiation through the cyclin-dependent kinase inhibitor p57Kip2, leading to lactation failure and pup starvation. Clinically, FUS levels are negatively correlated with milk production in lactating women. Overall, our results shed light on FUS as a negative regulator of milk production, providing a potential mechanism for the establishment of milk production from marsupial to eutherian mammals.
- 10 May 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-17
Open AccessFused in sarcoma (FUS) inhibits milk production efficiency in mammals
Efficient milk production in mammals confers evolutionary advantages by facilitating the transmission of energy from mother to offspring. However, the regulatory mechanism responsible for the gradual establishment of milk production efficiency in mammals, from marsupials to eutherians, remains elusive. Here, we find that mammary gland of the marsupial sugar glider contained milk components during adolescence, and that mammary gland development is less dynamically cyclic compared to that in placental mammals. Furthermore, fused in sarcoma (FUS) is found to be partially responsible for this establishment of low efficiency. In mouse model, FUS inhibit mammary epithelial cell differentiation through the cyclin-dependent kinase inhibitor p57Kip2, leading to lactation failure and pup starvation. Clinically, FUS levels are negatively correlated with milk production in lactating women. Overall, our results shed light on FUS as a negative regulator of milk production, providing a potential mechanism for the establishment of milk production from marsupial to eutherian mammals.
- Open Access
- 2 January 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-15
Mcam inhibits macrophage-mediated development of mammary gland through non-canonical Wnt signaling
While canonical Wnt signaling is well recognized for its crucial regulatory functions in cell fate decisions, the role of non-canonical Wnt signaling in adult stem cells remains elusive and contradictory. Here, we identified Mcam, a potential member of the non-canonical Wnt signaling, as an important negative regulator of mammary gland epithelial cells (MECs) by genome-scale CRISPR-Cas9 knockout (GeCKO) library screening. Loss of Mcam increases the clonogenicity and regenerative capacity of MECs, and promotes the proliferation, differentiation, and ductal morphogenesis of mammary epithelial in knockout mice. Mechanically, Mcam knockout recruits and polarizes macrophages through the Il4-Stat6 axis, thereby promoting secretion of the non-canonical Wnt ligand Wnt5a and its binding to the non-canonical Wnt signaling receptor Ryk to induce the above phenotypes. These findings reveal Mcam roles in mammary gland development by orchestrating communications between MECs and macrophages via a Wnt5a/Ryk axis, providing evidences for non-canonical Wnt signaling in mammary development.
- 2 January 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-15
Open AccessMcam inhibits macrophage-mediated development of mammary gland through non-canonical Wnt signaling
While canonical Wnt signaling is well recognized for its crucial regulatory functions in cell fate decisions, the role of non-canonical Wnt signaling in adult stem cells remains elusive and contradictory. Here, we identified Mcam, a potential member of the non-canonical Wnt signaling, as an important negative regulator of mammary gland epithelial cells (MECs) by genome-scale CRISPR-Cas9 knockout (GeCKO) library screening. Loss of Mcam increases the clonogenicity and regenerative capacity of MECs, and promotes the proliferation, differentiation, and ductal morphogenesis of mammary epithelial in knockout mice. Mechanically, Mcam knockout recruits and polarizes macrophages through the Il4-Stat6 axis, thereby promoting secretion of the non-canonical Wnt ligand Wnt5a and its binding to the non-canonical Wnt signaling receptor Ryk to induce the above phenotypes. These findings reveal Mcam roles in mammary gland development by orchestrating communications between MECs and macrophages via a Wnt5a/Ryk axis, providing evidences for non-canonical Wnt signaling in mammary development.
- Open Access
- 25 October 2016
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (6) , 10675-10691
Mammary gland stem cells and their application in breast cancer
Mammary gland stem cells and their application in breast cancer
- 25 October 2016
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (6) , 10675-10691
Open AccessMammary gland stem cells and their application in breast cancer
Mammary gland stem cells and their application in breast cancer